Lumida
/NAMS
⌘K
NewAmsterdam Pharma Company NV

NewAmsterdam Pharma Company NV

NAMS
$22.80USD+4.30%+0.94 today

MARKET CAP

2.7B

P/E (TTM)

FWD P/E

DAY RANGE

$21 – $23

52W RANGE

$21
$42

Buying

8

institutions

Selling

4

institutions

New Positions

2

this quarter

Filing Period

Q1 2026

latest 13-F

13-F Holdings

InstitutionActionShares HeldValueChangeChg %Weight
JH

Janus Henderson Group Plc

Q1 2026

BUY4.52 M144.51 M+2.18 M+75.6%0.04%
JC

Jpmorgan Chase & Co

Q2 2026

BUY1.13 M38.37 M+248.73 K+48.0%0.00%
BI

Blackrock, Inc.

Q2 2026

BUY1.06 M36.05 M+177.13 K+27.0%0.00%
WP

Woodline Partners LP

Q2 2026

SELL752.49 K25.50 M+-752.13 K-47.0%0.08%
CA

Citadel Advisors LLC

Q2 2026

SELL684.21 K23.19 M+-82.86 K-5.6%0.00%
MM

Millennium Management LLC

Q2 2026

BUY501.61 K17.00 M+197.77 K+74.8%0.01%
PA

Perceptive Advisors LLC

Q2 2026

BUYNEW500.00 K16.95 M+500.00 K+0.0%0.26%
EP

Eversept Partners, LP

Q2 2026

SELL275.47 K9.34 M+-10.29 K+2.1%0.48%
PA

Point72 Asset Management, L.P.

Q2 2026

BUY205.50 K6.96 M+169.10 K+497.7%0.01%
MG

Man Group Plc

Q2 2026

BUYNEW80.83 K2.74 M+80.83 K+0.0%0.00%
AC

Aqr Capital Management LLC

Q2 2026

BUY22.69 K769.00 K+12.31 K+131.3%0.00%
BH

Brevan Howard Capital Management LP

Q2 2026

SELL9.55 K323.58 K+-7.25 K-38.7%0.00%